BioHealth News Archive
TEDCO’s Tammi Thomas Elected President of the Maryland Economic Development Association
COLUMBIA, Md., (May 7, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced the appointment of its chief development and marketing officer, Tammi…
Read MoreTheriva Biologics Announces Pricing of $7.5 Million Public Offering
ROCKVILLE, Md., May 07, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed…
Read MoreGeneDx Announces Completion of Fabric Genomics Acquisition
GAITHERSBURG, Md. & OAKLAND, Calif.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the successful completion of…
Read MoreWBJ: AstraZeneca unveils $300M Rockville investment, a boost for MoCo amid federal cuts
By Sara Gilgore – Staff Reporter, Washington Business Journal - May 6, 2025 - AstraZeneca PLC (NYSE: AZN) has opened a new Rockville manufacturing hub, a whopping $300…
Read MoreGalimedix Completes First Phase 1 Dosing of Oral Alzheimer’s Drug GAL-101
KENSINGTON, Md. and MUNICH and MARTINSRIED, Germany, May 06, 2025 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, Inc. (“Galimedix”), a Phase 2 clinical-stage biotechnology company developing…
Read MoreNovavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan
GAITHERSBURG, Md., May 5, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has updated the terms of the previously announced collaboration and licensing agreement (CLA) with Takeda. The improved…
Read MoreSuccessful 2nd Annual “Stem Cell and Regenerative Medicine Tech Showcase” Held on April 29, 2025
Innovators in Regenerative Medicine Gathered to Drive Healing and Hope BALTIMORE, MD. | May 6, 2025 – The Maryland Stem Cell Research Fund (MSCRF)…
Read MorePQE Group US Earns Great Place to Work Certification™
For its fourth consecutive year, the company is recognized with this certification Rockville, MD, May 5, 2025. PQE Group is proud to announce that,…
Read MoreUMSOM: New Innovation Alliance Aims to Drive New Med Tech Ventures In Region
April 28, 2025 | Jon Kelvey - A new collaboration bringing entrepreneurs and investors together with physician-scientists, surgeons, and medical technologists promises to launch the Baltimore region as…
Read MoreVerImmune Awarded ~$470K CDMRP Grant to Drive Innovation in ViP-Based Therapeutics for Advanced Melanoma
Washington DC & Singapore – April 29th, 2025- VerImmune, Inc. (“VerImmune”), a biotechnology company developing innovative Virus-inspired Particle (ViP) modalities, announced today it has…
Read MoreEmergent BioSolutions Announces Agreement to Supply the Ontario Ministry of Health with NARCAN®
WINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three-year agreement with a value of approximately…
Read MoreBeyond the Device: Neopenda’s Human-Centered Approach to Health Tech
More than a decade ago, a young engineer named Sona Shah stepped into a classroom in rural Kenya—and the beginning of a life-changing journey.…
Read MoreRoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing
FREDERICK, Md., April 30, 2025 /PRNewswire/ -- RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services,…
Read MoreSonavex Receives FDA 510(k) Clearance for EchoMap™ Device
Baltimore, MD (April 28th, 2025) – Sonavex, Inc., a privately held medical device company with ultrasound technologies that deliver quantitative blood flow and other…
Read MoreClasp Therapeutics Begins First Human Trial of New Immune Therapy Designed to Precisely Attack Cancer Cells
Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial With a First-in-Class T-Cell Engager Designed to Target Cancer Cells With Absolute Specificity CAMBRIDGE,…
Read More